Literature DB >> 5134893

Hypertension and low plasma renin activity: presumptive evidence for mineralocorticoid excess.

R F Spark, J C Melby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5134893     DOI: 10.7326/0003-4819-75-6-831

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  17 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Jeremiah Metzger lecture, 1974: The renin-angiotensin system. Some new aspects.

Authors:  J Genest; R Boucher; O Kuchel; J M Rojo-Ortega; W Nowaczynski
Journal:  Trans Am Clin Climatol Assoc       Date:  1975

3.  Aldosterone to renin ratio as a predictor of diuretic response.

Authors:  Steven A Atlas
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

Review 4.  Stepped care for hypertension is dead, but what will replace it?

Authors:  J D Spence
Journal:  CMAJ       Date:  1989-05-15       Impact factor: 8.262

5.  Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study.

Authors:  P O Lim; R T Jung; T M MacDonald
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

6.  Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.

Authors:  R Fagard; A Amery; P Lijnen; T Reybrouck
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

7.  [Kidney and hypertension].

Authors:  F Gross
Journal:  Klin Wochenschr       Date:  1972-07-01

8.  [Antihypertensive effect of spironolactone (author's transl)].

Authors:  H Liebau; W Jarosch-von Schweder
Journal:  Klin Wochenschr       Date:  1974-09-01

9.  Editorial: New knowledge of benign essential hypertension.

Authors:  J C Laidlaw
Journal:  Can Med Assoc J       Date:  1973-09-15       Impact factor: 8.262

10.  Spironolactone in essential hypertension: evidence against its effect through mineralocorticoid antagonism.

Authors:  B I Hoffbrand; C J Edmonds; T Smith
Journal:  Br Med J       Date:  1976-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.